Shots:

• The US FDA has granted 510(k) clearance to the company’s Moda-flx Hemodialysis System for patients with renal failure
• The device is developed for acute or chronic renal failure with/without ultrafiltration, in an acute, post-acute, or chronic care facility. Available treatments are Intermittent Hemodialysis (IHD), Sustained Low Efficiency Dialysis (SLED/SLEDD) & Prolonged Intermittent Renal Replacement Therapy (PIRRT)
• The system features variable flow rates, integrated reverse osmosis water filtration, and an intuitive graphical user interface, enabling customization of hemodialysis based on patient needs